Hudson Bay Capital Management LP - EUCRATES BIOMEDICAL ACQU COR ownership

EUCRATES BIOMEDICAL ACQU COR's ticker is EUCR and the CUSIP is G3141W106. A total of 6 filers reported holding EUCRATES BIOMEDICAL ACQU COR in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Hudson Bay Capital Management LP ownership history of EUCRATES BIOMEDICAL ACQU COR
ValueSharesWeighting
Q3 2022$6,529,000
-4.1%
650,920
-5.3%
0.06%
+13.7%
Q2 2022$6,807,000
+34.8%
687,528
+34.1%
0.05%
-25.0%
Q1 2022$5,048,000
+19.3%
512,528
+18.3%
0.07%
+58.1%
Q4 2021$4,230,000
-0.2%
433,3820.0%0.04%
-24.6%
Q3 2021$4,238,000
-0.7%
433,3820.0%0.06%
+9.6%
Q2 2021$4,267,000
+8.8%
433,382
+9.3%
0.05%
+8.3%
Q1 2021$3,921,000
-51.2%
396,480
-50.4%
0.05%
+11.6%
Q4 2020$8,040,000799,9980.04%
Other shareholders
EUCRATES BIOMEDICAL ACQU COR shareholders Q4 2022
NameSharesValueWeighting ↓
Altium Capital Management LP 400,000$4,008,0001.47%
683 Capital Management, LLC 600,000$6,012,0000.46%
CVI Holdings, LLC 367,552$3,687,0000.29%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$2,004,0000.26%
SkyView Investment Advisors, LLC 71,773$719,0000.21%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 999,999$10,020,0000.20%
GLAZER CAPITAL, LLC 1,022,411$10,245,0000.19%
METEORA CAPITAL, LLC 56,076$562,0000.14%
Cowen Investment Management LLC 50,000$501,0000.11%
First Trust Capital Management L.P. 208,598$2,090,0000.10%
View complete list of EUCRATES BIOMEDICAL ACQU COR shareholders